nodes	percent_of_prediction	percent_of_DWPC	metapath
Ceftazidime—SLC15A2—Chlorpropamide—type 2 diabetes mellitus	0.0843	0.11	CbGbCtD
Ceftazidime—SLC15A2—Tolbutamide—type 2 diabetes mellitus	0.0751	0.0981	CbGbCtD
Ceftazidime—SLC15A1—Chlorpropamide—type 2 diabetes mellitus	0.0726	0.0948	CbGbCtD
Ceftazidime—SLC15A2—Ramipril—type 2 diabetes mellitus	0.0669	0.0874	CbGbCtD
Ceftazidime—SLC15A1—Tolbutamide—type 2 diabetes mellitus	0.0647	0.0845	CbGbCtD
Ceftazidime—SLC15A2—Nateglinide—type 2 diabetes mellitus	0.0638	0.0834	CbGbCtD
Ceftazidime—SLC15A1—Ramipril—type 2 diabetes mellitus	0.0576	0.0753	CbGbCtD
Ceftazidime—SLC15A1—Nateglinide—type 2 diabetes mellitus	0.055	0.0719	CbGbCtD
Ceftazidime—SLC15A2—Glyburide—type 2 diabetes mellitus	0.0431	0.0564	CbGbCtD
Ceftazidime—SLC22A6—Chlorpropamide—type 2 diabetes mellitus	0.04	0.0522	CbGbCtD
Ceftazidime—SLC15A1—Glyburide—type 2 diabetes mellitus	0.0371	0.0485	CbGbCtD
Ceftazidime—SLC22A6—Tolbutamide—type 2 diabetes mellitus	0.0356	0.0466	CbGbCtD
Ceftazidime—SLC22A6—Nateglinide—type 2 diabetes mellitus	0.0303	0.0396	CbGbCtD
Ceftazidime—SLC22A6—Glyburide—type 2 diabetes mellitus	0.0205	0.0267	CbGbCtD
Ceftazidime—SLC22A6—Losartan—type 2 diabetes mellitus	0.0187	0.0245	CbGbCtD
Ceftazidime—SLC15A2—Transport of inorganic cations/anions and amino acids/oligopeptides—SLC26A9—type 2 diabetes mellitus	0.000361	0.0393	CbGpPWpGaD
Ceftazidime—SLC15A1—Transport of inorganic cations/anions and amino acids/oligopeptides—SLC26A9—type 2 diabetes mellitus	0.000335	0.0365	CbGpPWpGaD
Ceftazidime—SLC22A5—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—SLC5A4—type 2 diabetes mellitus	0.000216	0.0235	CbGpPWpGaD
Ceftazidime—Urticaria—Sitagliptin—type 2 diabetes mellitus	0.000173	0.000766	CcSEcCtD
Ceftazidime—Angiopathy—Metformin—type 2 diabetes mellitus	0.000173	0.000766	CcSEcCtD
Ceftazidime—Abdominal pain—Glimepiride—type 2 diabetes mellitus	0.000172	0.000765	CcSEcCtD
Ceftazidime—Hypersensitivity—Glipizide—type 2 diabetes mellitus	0.000172	0.000764	CcSEcCtD
Ceftazidime—Abdominal pain—Sitagliptin—type 2 diabetes mellitus	0.000172	0.000763	CcSEcCtD
Ceftazidime—Pancytopenia—Ramipril—type 2 diabetes mellitus	0.000172	0.000763	CcSEcCtD
Ceftazidime—Immune system disorder—Metformin—type 2 diabetes mellitus	0.000172	0.000762	CcSEcCtD
Ceftazidime—Convulsion—Gliclazide—type 2 diabetes mellitus	0.000172	0.000761	CcSEcCtD
Ceftazidime—Vision blurred—Valsartan—type 2 diabetes mellitus	0.000171	0.00076	CcSEcCtD
Ceftazidime—SLC22A5—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—SLC30A8—type 2 diabetes mellitus	0.00017	0.0185	CbGpPWpGaD
Ceftazidime—Gastrointestinal disorder—Bromocriptine—type 2 diabetes mellitus	0.00017	0.000754	CcSEcCtD
Ceftazidime—Vision blurred—Orlistat—type 2 diabetes mellitus	0.000169	0.000751	CcSEcCtD
Ceftazidime—Neutropenia—Ramipril—type 2 diabetes mellitus	0.000169	0.000751	CcSEcCtD
Ceftazidime—Rash—Rosiglitazone—type 2 diabetes mellitus	0.000168	0.000747	CcSEcCtD
Ceftazidime—Dermatitis—Rosiglitazone—type 2 diabetes mellitus	0.000168	0.000746	CcSEcCtD
Ceftazidime—Hypotension—Glyburide—type 2 diabetes mellitus	0.000168	0.000746	CcSEcCtD
Ceftazidime—Nausea—Repaglinide—type 2 diabetes mellitus	0.000168	0.000745	CcSEcCtD
Ceftazidime—Unspecified disorder of skin and subcutaneous tissue—Gliclazide—type 2 diabetes mellitus	0.000167	0.000743	CcSEcCtD
Ceftazidime—Headache—Rosiglitazone—type 2 diabetes mellitus	0.000167	0.000742	CcSEcCtD
Ceftazidime—Flushing—Irbesartan—type 2 diabetes mellitus	0.000167	0.000739	CcSEcCtD
Ceftazidime—Angioedema—Valsartan—type 2 diabetes mellitus	0.000166	0.000737	CcSEcCtD
Ceftazidime—Pruritus—Glipizide—type 2 diabetes mellitus	0.000165	0.000734	CcSEcCtD
Ceftazidime—Hypersensitivity—Pioglitazone—type 2 diabetes mellitus	0.000165	0.000732	CcSEcCtD
Ceftazidime—Angioedema—Orlistat—type 2 diabetes mellitus	0.000164	0.000728	CcSEcCtD
Ceftazidime—SLC22A5—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—SLC5A2—type 2 diabetes mellitus	0.000164	0.0178	CbGpPWpGaD
Ceftazidime—SLC22A6—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—SLC5A4—type 2 diabetes mellitus	0.000163	0.0178	CbGpPWpGaD
Ceftazidime—Angiopathy—Irbesartan—type 2 diabetes mellitus	0.000163	0.000723	CcSEcCtD
Ceftazidime—Dysgeusia—Metformin—type 2 diabetes mellitus	0.000162	0.00072	CcSEcCtD
Ceftazidime—Immune system disorder—Irbesartan—type 2 diabetes mellitus	0.000162	0.000719	CcSEcCtD
Ceftazidime—Paraesthesia—Glyburide—type 2 diabetes mellitus	0.000162	0.000717	CcSEcCtD
Ceftazidime—SLC15A2—SLC-mediated transmembrane transport—SLC26A9—type 2 diabetes mellitus	0.000161	0.0176	CbGpPWpGaD
Ceftazidime—Gastrointestinal pain—Bromocriptine—type 2 diabetes mellitus	0.000161	0.000714	CcSEcCtD
Ceftazidime—Hypersensitivity—Glimepiride—type 2 diabetes mellitus	0.000161	0.000713	CcSEcCtD
Ceftazidime—Hypersensitivity—Sitagliptin—type 2 diabetes mellitus	0.00016	0.000711	CcSEcCtD
Ceftazidime—Stevens-Johnson syndrome—Ramipril—type 2 diabetes mellitus	0.00016	0.00071	CcSEcCtD
Ceftazidime—Diarrhoea—Glipizide—type 2 diabetes mellitus	0.00016	0.00071	CcSEcCtD
Ceftazidime—Erythema multiforme—Losartan—type 2 diabetes mellitus	0.00016	0.000709	CcSEcCtD
Ceftazidime—Renal failure—Ramipril—type 2 diabetes mellitus	0.000159	0.000704	CcSEcCtD
Ceftazidime—Nausea—Rosiglitazone—type 2 diabetes mellitus	0.000159	0.000704	CcSEcCtD
Ceftazidime—Nervous system disorder—Gliclazide—type 2 diabetes mellitus	0.000158	0.000703	CcSEcCtD
Ceftazidime—Thrombocytopenia—Gliclazide—type 2 diabetes mellitus	0.000158	0.000702	CcSEcCtD
Ceftazidime—Jaundice—Ramipril—type 2 diabetes mellitus	0.000157	0.000698	CcSEcCtD
Ceftazidime—Skin disorder—Gliclazide—type 2 diabetes mellitus	0.000157	0.000696	CcSEcCtD
Ceftazidime—Flushing—Losartan—type 2 diabetes mellitus	0.000157	0.000696	CcSEcCtD
Ceftazidime—Urticaria—Bromocriptine—type 2 diabetes mellitus	0.000156	0.000694	CcSEcCtD
Ceftazidime—Vision blurred—Metformin—type 2 diabetes mellitus	0.000156	0.000692	CcSEcCtD
Ceftazidime—Convulsion—Orlistat—type 2 diabetes mellitus	0.000156	0.000691	CcSEcCtD
Ceftazidime—Abdominal pain—Bromocriptine—type 2 diabetes mellitus	0.000156	0.00069	CcSEcCtD
Ceftazidime—Body temperature increased—Bromocriptine—type 2 diabetes mellitus	0.000156	0.00069	CcSEcCtD
Ceftazidime—Gastrointestinal disorder—Glyburide—type 2 diabetes mellitus	0.000155	0.000689	CcSEcCtD
Ceftazidime—Tremor—Metformin—type 2 diabetes mellitus	0.000155	0.000688	CcSEcCtD
Ceftazidime—Dizziness—Glipizide—type 2 diabetes mellitus	0.000155	0.000686	CcSEcCtD
Ceftazidime—Pruritus—Glimepiride—type 2 diabetes mellitus	0.000154	0.000685	CcSEcCtD
Ceftazidime—Unspecified disorder of skin and subcutaneous tissue—Valsartan—type 2 diabetes mellitus	0.000154	0.000682	CcSEcCtD
Ceftazidime—Angiopathy—Losartan—type 2 diabetes mellitus	0.000153	0.00068	CcSEcCtD
Ceftazidime—Diarrhoea—Pioglitazone—type 2 diabetes mellitus	0.000153	0.00068	CcSEcCtD
Ceftazidime—Dysgeusia—Irbesartan—type 2 diabetes mellitus	0.000153	0.000679	CcSEcCtD
Ceftazidime—Hepatobiliary disease—Ramipril—type 2 diabetes mellitus	0.000153	0.000677	CcSEcCtD
Ceftazidime—Unspecified disorder of skin and subcutaneous tissue—Orlistat—type 2 diabetes mellitus	0.000152	0.000674	CcSEcCtD
Ceftazidime—Hypotension—Gliclazide—type 2 diabetes mellitus	0.000151	0.00067	CcSEcCtD
Ceftazidime—Agranulocytosis—Ramipril—type 2 diabetes mellitus	0.000151	0.000668	CcSEcCtD
Ceftazidime—SLC15A1—SLC-mediated transmembrane transport—SLC26A9—type 2 diabetes mellitus	0.00015	0.0163	CbGpPWpGaD
Ceftazidime—Diarrhoea—Glimepiride—type 2 diabetes mellitus	0.000149	0.000662	CcSEcCtD
Ceftazidime—Diarrhoea—Sitagliptin—type 2 diabetes mellitus	0.000149	0.00066	CcSEcCtD
Ceftazidime—Vomiting—Glipizide—type 2 diabetes mellitus	0.000149	0.000659	CcSEcCtD
Ceftazidime—Anaphylactic shock—Valsartan—type 2 diabetes mellitus	0.000148	0.000658	CcSEcCtD
Ceftazidime—Dizziness—Pioglitazone—type 2 diabetes mellitus	0.000148	0.000657	CcSEcCtD
Ceftazidime—Rash—Glipizide—type 2 diabetes mellitus	0.000147	0.000654	CcSEcCtD
Ceftazidime—Vision blurred—Irbesartan—type 2 diabetes mellitus	0.000147	0.000653	CcSEcCtD
Ceftazidime—Dermatitis—Glipizide—type 2 diabetes mellitus	0.000147	0.000653	CcSEcCtD
Ceftazidime—SLC22A5—SLC-mediated transmembrane transport—SLC26A9—type 2 diabetes mellitus	0.000147	0.016	CbGpPWpGaD
Ceftazidime—Gastrointestinal pain—Glyburide—type 2 diabetes mellitus	0.000147	0.000653	CcSEcCtD
Ceftazidime—Anaphylactic shock—Orlistat—type 2 diabetes mellitus	0.000147	0.000651	CcSEcCtD
Ceftazidime—Headache—Glipizide—type 2 diabetes mellitus	0.000146	0.00065	CcSEcCtD
Ceftazidime—Tremor—Irbesartan—type 2 diabetes mellitus	0.000146	0.00065	CcSEcCtD
Ceftazidime—Nervous system disorder—Valsartan—type 2 diabetes mellitus	0.000146	0.000646	CcSEcCtD
Ceftazidime—Thrombocytopenia—Valsartan—type 2 diabetes mellitus	0.000145	0.000645	CcSEcCtD
Ceftazidime—Paraesthesia—Gliclazide—type 2 diabetes mellitus	0.000145	0.000644	CcSEcCtD
Ceftazidime—Dizziness—Glimepiride—type 2 diabetes mellitus	0.000144	0.00064	CcSEcCtD
Ceftazidime—Skin disorder—Valsartan—type 2 diabetes mellitus	0.000144	0.00064	CcSEcCtD
Ceftazidime—Dysgeusia—Losartan—type 2 diabetes mellitus	0.000144	0.000639	CcSEcCtD
Ceftazidime—Nervous system disorder—Orlistat—type 2 diabetes mellitus	0.000144	0.000638	CcSEcCtD
Ceftazidime—Dizziness—Sitagliptin—type 2 diabetes mellitus	0.000144	0.000638	CcSEcCtD
Ceftazidime—Agitation—Irbesartan—type 2 diabetes mellitus	0.000144	0.000637	CcSEcCtD
Ceftazidime—Urticaria—Glyburide—type 2 diabetes mellitus	0.000143	0.000634	CcSEcCtD
Ceftazidime—Angioedema—Irbesartan—type 2 diabetes mellitus	0.000143	0.000634	CcSEcCtD
Ceftazidime—Skin disorder—Orlistat—type 2 diabetes mellitus	0.000142	0.000632	CcSEcCtD
Ceftazidime—Abdominal pain—Glyburide—type 2 diabetes mellitus	0.000142	0.000631	CcSEcCtD
Ceftazidime—Headache—Pioglitazone—type 2 diabetes mellitus	0.00014	0.000622	CcSEcCtD
Ceftazidime—Unspecified disorder of skin and subcutaneous tissue—Metformin—type 2 diabetes mellitus	0.00014	0.000621	CcSEcCtD
Ceftazidime—Leukopenia—Irbesartan—type 2 diabetes mellitus	0.00014	0.000621	CcSEcCtD
Ceftazidime—Gastrointestinal disorder—Gliclazide—type 2 diabetes mellitus	0.00014	0.000619	CcSEcCtD
Ceftazidime—Nausea—Glipizide—type 2 diabetes mellitus	0.000139	0.000616	CcSEcCtD
Ceftazidime—Vomiting—Glimepiride—type 2 diabetes mellitus	0.000139	0.000615	CcSEcCtD
Ceftazidime—Hypotension—Valsartan—type 2 diabetes mellitus	0.000139	0.000615	CcSEcCtD
Ceftazidime—Vision blurred—Losartan—type 2 diabetes mellitus	0.000139	0.000615	CcSEcCtD
Ceftazidime—Vomiting—Sitagliptin—type 2 diabetes mellitus	0.000138	0.000613	CcSEcCtD
Ceftazidime—Pain—Gliclazide—type 2 diabetes mellitus	0.000138	0.000613	CcSEcCtD
Ceftazidime—Tremor—Losartan—type 2 diabetes mellitus	0.000138	0.000611	CcSEcCtD
Ceftazidime—Rash—Glimepiride—type 2 diabetes mellitus	0.000138	0.00061	CcSEcCtD
Ceftazidime—Dermatitis—Glimepiride—type 2 diabetes mellitus	0.000137	0.00061	CcSEcCtD
Ceftazidime—Rash—Sitagliptin—type 2 diabetes mellitus	0.000137	0.000608	CcSEcCtD
Ceftazidime—Dermatitis—Sitagliptin—type 2 diabetes mellitus	0.000137	0.000608	CcSEcCtD
Ceftazidime—Erythema multiforme—Ramipril—type 2 diabetes mellitus	0.000137	0.000608	CcSEcCtD
Ceftazidime—Headache—Glimepiride—type 2 diabetes mellitus	0.000137	0.000606	CcSEcCtD
Ceftazidime—Headache—Sitagliptin—type 2 diabetes mellitus	0.000136	0.000604	CcSEcCtD
Ceftazidime—Agitation—Losartan—type 2 diabetes mellitus	0.000135	0.0006	CcSEcCtD
Ceftazidime—Diarrhoea—Bromocriptine—type 2 diabetes mellitus	0.000135	0.000597	CcSEcCtD
Ceftazidime—Flushing—Ramipril—type 2 diabetes mellitus	0.000134	0.000597	CcSEcCtD
Ceftazidime—Angioedema—Losartan—type 2 diabetes mellitus	0.000134	0.000596	CcSEcCtD
Ceftazidime—Paraesthesia—Valsartan—type 2 diabetes mellitus	0.000133	0.000591	CcSEcCtD
Ceftazidime—Hypersensitivity—Glyburide—type 2 diabetes mellitus	0.000133	0.000588	CcSEcCtD
Ceftazidime—Nervous system disorder—Metformin—type 2 diabetes mellitus	0.000133	0.000588	CcSEcCtD
Ceftazidime—Thrombocytopenia—Metformin—type 2 diabetes mellitus	0.000132	0.000587	CcSEcCtD
Ceftazidime—Unspecified disorder of skin and subcutaneous tissue—Irbesartan—type 2 diabetes mellitus	0.000132	0.000586	CcSEcCtD
Ceftazidime—Gastrointestinal pain—Gliclazide—type 2 diabetes mellitus	0.000132	0.000586	CcSEcCtD
Ceftazidime—Paraesthesia—Orlistat—type 2 diabetes mellitus	0.000132	0.000584	CcSEcCtD
Ceftazidime—Leukopenia—Losartan—type 2 diabetes mellitus	0.000132	0.000584	CcSEcCtD
Ceftazidime—Skin disorder—Metformin—type 2 diabetes mellitus	0.000131	0.000582	CcSEcCtD
Ceftazidime—Immune system disorder—Ramipril—type 2 diabetes mellitus	0.000131	0.000581	CcSEcCtD
Ceftazidime—Dizziness—Bromocriptine—type 2 diabetes mellitus	0.00013	0.000577	CcSEcCtD
Ceftazidime—Nausea—Glimepiride—type 2 diabetes mellitus	0.00013	0.000575	CcSEcCtD
Ceftazidime—Nausea—Sitagliptin—type 2 diabetes mellitus	0.000129	0.000573	CcSEcCtD
Ceftazidime—SLC22A6—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—SLC30A8—type 2 diabetes mellitus	0.000128	0.014	CbGpPWpGaD
Ceftazidime—Urticaria—Gliclazide—type 2 diabetes mellitus	0.000128	0.000569	CcSEcCtD
Ceftazidime—Gastrointestinal disorder—Valsartan—type 2 diabetes mellitus	0.000128	0.000568	CcSEcCtD
Ceftazidime—Body temperature increased—Gliclazide—type 2 diabetes mellitus	0.000128	0.000567	CcSEcCtD
Ceftazidime—Abdominal pain—Gliclazide—type 2 diabetes mellitus	0.000128	0.000567	CcSEcCtD
Ceftazidime—Anaphylactic shock—Irbesartan—type 2 diabetes mellitus	0.000128	0.000566	CcSEcCtD
Ceftazidime—Pruritus—Glyburide—type 2 diabetes mellitus	0.000127	0.000565	CcSEcCtD
Ceftazidime—Gastrointestinal disorder—Orlistat—type 2 diabetes mellitus	0.000127	0.000562	CcSEcCtD
Ceftazidime—Hypotension—Metformin—type 2 diabetes mellitus	0.000126	0.00056	CcSEcCtD
Ceftazidime—Pain—Orlistat—type 2 diabetes mellitus	0.000125	0.000556	CcSEcCtD
Ceftazidime—Vomiting—Bromocriptine—type 2 diabetes mellitus	0.000125	0.000555	CcSEcCtD
Ceftazidime—Nervous system disorder—Irbesartan—type 2 diabetes mellitus	0.000125	0.000555	CcSEcCtD
Ceftazidime—Thrombocytopenia—Irbesartan—type 2 diabetes mellitus	0.000125	0.000554	CcSEcCtD
Ceftazidime—Rash—Bromocriptine—type 2 diabetes mellitus	0.000124	0.000551	CcSEcCtD
Ceftazidime—Dermatitis—Bromocriptine—type 2 diabetes mellitus	0.000124	0.00055	CcSEcCtD
Ceftazidime—Skin disorder—Irbesartan—type 2 diabetes mellitus	0.000124	0.00055	CcSEcCtD
Ceftazidime—SLC22A6—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—SLC5A2—type 2 diabetes mellitus	0.000124	0.0135	CbGpPWpGaD
Ceftazidime—Dysgeusia—Ramipril—type 2 diabetes mellitus	0.000124	0.000548	CcSEcCtD
Ceftazidime—Headache—Bromocriptine—type 2 diabetes mellitus	0.000123	0.000547	CcSEcCtD
Ceftazidime—Diarrhoea—Glyburide—type 2 diabetes mellitus	0.000123	0.000546	CcSEcCtD
Ceftazidime—Gastrointestinal pain—Valsartan—type 2 diabetes mellitus	0.000121	0.000538	CcSEcCtD
Ceftazidime—Paraesthesia—Metformin—type 2 diabetes mellitus	0.000121	0.000538	CcSEcCtD
Ceftazidime—Anaphylactic shock—Losartan—type 2 diabetes mellitus	0.00012	0.000533	CcSEcCtD
Ceftazidime—Gastrointestinal pain—Orlistat—type 2 diabetes mellitus	0.00012	0.000532	CcSEcCtD
Ceftazidime—Hypotension—Irbesartan—type 2 diabetes mellitus	0.000119	0.000529	CcSEcCtD
Ceftazidime—Hypersensitivity—Gliclazide—type 2 diabetes mellitus	0.000119	0.000528	CcSEcCtD
Ceftazidime—Tremor—Ramipril—type 2 diabetes mellitus	0.000118	0.000524	CcSEcCtD
Ceftazidime—Urticaria—Valsartan—type 2 diabetes mellitus	0.000118	0.000523	CcSEcCtD
Ceftazidime—Nervous system disorder—Losartan—type 2 diabetes mellitus	0.000118	0.000522	CcSEcCtD
Ceftazidime—Thrombocytopenia—Losartan—type 2 diabetes mellitus	0.000118	0.000521	CcSEcCtD
Ceftazidime—Abdominal pain—Valsartan—type 2 diabetes mellitus	0.000117	0.000521	CcSEcCtD
Ceftazidime—Nausea—Bromocriptine—type 2 diabetes mellitus	0.000117	0.000519	CcSEcCtD
Ceftazidime—Gastrointestinal disorder—Metformin—type 2 diabetes mellitus	0.000117	0.000518	CcSEcCtD
Ceftazidime—Urticaria—Orlistat—type 2 diabetes mellitus	0.000117	0.000517	CcSEcCtD
Ceftazidime—SLC15A2—Transport of inorganic cations/anions and amino acids/oligopeptides—SLC9A1—type 2 diabetes mellitus	0.000116	0.0127	CbGpPWpGaD
Ceftazidime—Abdominal pain—Orlistat—type 2 diabetes mellitus	0.000116	0.000514	CcSEcCtD
Ceftazidime—Body temperature increased—Orlistat—type 2 diabetes mellitus	0.000116	0.000514	CcSEcCtD
Ceftazidime—Agitation—Ramipril—type 2 diabetes mellitus	0.000116	0.000514	CcSEcCtD
Ceftazidime—Angioedema—Ramipril—type 2 diabetes mellitus	0.000115	0.000511	CcSEcCtD
Ceftazidime—Paraesthesia—Irbesartan—type 2 diabetes mellitus	0.000115	0.000508	CcSEcCtD
Ceftazidime—Vomiting—Glyburide—type 2 diabetes mellitus	0.000114	0.000507	CcSEcCtD
Ceftazidime—Pruritus—Gliclazide—type 2 diabetes mellitus	0.000114	0.000507	CcSEcCtD
Ceftazidime—Rash—Glyburide—type 2 diabetes mellitus	0.000113	0.000503	CcSEcCtD
Ceftazidime—Dermatitis—Glyburide—type 2 diabetes mellitus	0.000113	0.000503	CcSEcCtD
Ceftazidime—Leukopenia—Ramipril—type 2 diabetes mellitus	0.000113	0.000501	CcSEcCtD
Ceftazidime—Headache—Glyburide—type 2 diabetes mellitus	0.000113	0.0005	CcSEcCtD
Ceftazidime—Hypotension—Losartan—type 2 diabetes mellitus	0.000112	0.000498	CcSEcCtD
Ceftazidime—SLC22A5—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—SLC2A2—type 2 diabetes mellitus	0.000112	0.0122	CbGpPWpGaD
Ceftazidime—SLC22A6—SLC-mediated transmembrane transport—SLC26A9—type 2 diabetes mellitus	0.000111	0.0121	CbGpPWpGaD
Ceftazidime—Diarrhoea—Gliclazide—type 2 diabetes mellitus	0.000111	0.00049	CcSEcCtD
Ceftazidime—Gastrointestinal pain—Metformin—type 2 diabetes mellitus	0.000111	0.00049	CcSEcCtD
Ceftazidime—Gastrointestinal disorder—Irbesartan—type 2 diabetes mellitus	0.00011	0.000489	CcSEcCtD
Ceftazidime—Hypersensitivity—Valsartan—type 2 diabetes mellitus	0.000109	0.000485	CcSEcCtD
Ceftazidime—Convulsion—Ramipril—type 2 diabetes mellitus	0.000109	0.000485	CcSEcCtD
Ceftazidime—Pain—Irbesartan—type 2 diabetes mellitus	0.000109	0.000484	CcSEcCtD
Ceftazidime—Hypersensitivity—Orlistat—type 2 diabetes mellitus	0.000108	0.000479	CcSEcCtD
Ceftazidime—SLC15A1—Transport of inorganic cations/anions and amino acids/oligopeptides—SLC9A1—type 2 diabetes mellitus	0.000108	0.0117	CbGpPWpGaD
Ceftazidime—Paraesthesia—Losartan—type 2 diabetes mellitus	0.000108	0.000478	CcSEcCtD
Ceftazidime—SLC15A2—SLC-mediated transmembrane transport—SLC5A4—type 2 diabetes mellitus	0.000108	0.0117	CbGpPWpGaD
Ceftazidime—Urticaria—Metformin—type 2 diabetes mellitus	0.000107	0.000476	CcSEcCtD
Ceftazidime—Nausea—Glyburide—type 2 diabetes mellitus	0.000107	0.000474	CcSEcCtD
Ceftazidime—Abdominal pain—Metformin—type 2 diabetes mellitus	0.000107	0.000474	CcSEcCtD
Ceftazidime—Dizziness—Gliclazide—type 2 diabetes mellitus	0.000107	0.000474	CcSEcCtD
Ceftazidime—Unspecified disorder of skin and subcutaneous tissue—Ramipril—type 2 diabetes mellitus	0.000107	0.000473	CcSEcCtD
Ceftazidime—Pruritus—Valsartan—type 2 diabetes mellitus	0.000105	0.000466	CcSEcCtD
Ceftazidime—Gastrointestinal pain—Irbesartan—type 2 diabetes mellitus	0.000104	0.000463	CcSEcCtD
Ceftazidime—SLC15A2—SLC-mediated transmembrane transport—G6PC—type 2 diabetes mellitus	0.000104	0.0113	CbGpPWpGaD
Ceftazidime—Pruritus—Orlistat—type 2 diabetes mellitus	0.000104	0.00046	CcSEcCtD
Ceftazidime—Anaphylactic shock—Ramipril—type 2 diabetes mellitus	0.000103	0.000457	CcSEcCtD
Ceftazidime—Vomiting—Gliclazide—type 2 diabetes mellitus	0.000103	0.000456	CcSEcCtD
Ceftazidime—Pain—Losartan—type 2 diabetes mellitus	0.000103	0.000455	CcSEcCtD
Ceftazidime—Rash—Gliclazide—type 2 diabetes mellitus	0.000102	0.000452	CcSEcCtD
Ceftazidime—Dermatitis—Gliclazide—type 2 diabetes mellitus	0.000102	0.000451	CcSEcCtD
Ceftazidime—Diarrhoea—Valsartan—type 2 diabetes mellitus	0.000102	0.000451	CcSEcCtD
Ceftazidime—Urticaria—Irbesartan—type 2 diabetes mellitus	0.000101	0.00045	CcSEcCtD
Ceftazidime—Headache—Gliclazide—type 2 diabetes mellitus	0.000101	0.000449	CcSEcCtD
Ceftazidime—Nervous system disorder—Ramipril—type 2 diabetes mellitus	0.000101	0.000448	CcSEcCtD
Ceftazidime—Body temperature increased—Irbesartan—type 2 diabetes mellitus	0.000101	0.000447	CcSEcCtD
Ceftazidime—Abdominal pain—Irbesartan—type 2 diabetes mellitus	0.000101	0.000447	CcSEcCtD
Ceftazidime—Thrombocytopenia—Ramipril—type 2 diabetes mellitus	0.000101	0.000447	CcSEcCtD
Ceftazidime—Diarrhoea—Orlistat—type 2 diabetes mellitus	0.0001	0.000445	CcSEcCtD
Ceftazidime—Skin disorder—Ramipril—type 2 diabetes mellitus	0.0001	0.000444	CcSEcCtD
Ceftazidime—SLC15A1—SLC-mediated transmembrane transport—SLC5A4—type 2 diabetes mellitus	9.99e-05	0.0109	CbGpPWpGaD
Ceftazidime—SLC22A5—SLC-mediated transmembrane transport—SLC5A4—type 2 diabetes mellitus	9.82e-05	0.0107	CbGpPWpGaD
Ceftazidime—Gastrointestinal pain—Losartan—type 2 diabetes mellitus	9.82e-05	0.000435	CcSEcCtD
Ceftazidime—Dizziness—Valsartan—type 2 diabetes mellitus	9.82e-05	0.000435	CcSEcCtD
Ceftazidime—Dizziness—Orlistat—type 2 diabetes mellitus	9.7e-05	0.00043	CcSEcCtD
Ceftazidime—SLC15A1—SLC-mediated transmembrane transport—G6PC—type 2 diabetes mellitus	9.65e-05	0.0105	CbGpPWpGaD
Ceftazidime—Hypotension—Ramipril—type 2 diabetes mellitus	9.62e-05	0.000427	CcSEcCtD
Ceftazidime—Nausea—Gliclazide—type 2 diabetes mellitus	9.6e-05	0.000426	CcSEcCtD
Ceftazidime—Pruritus—Metformin—type 2 diabetes mellitus	9.57e-05	0.000424	CcSEcCtD
Ceftazidime—Urticaria—Losartan—type 2 diabetes mellitus	9.54e-05	0.000423	CcSEcCtD
Ceftazidime—Body temperature increased—Losartan—type 2 diabetes mellitus	9.49e-05	0.000421	CcSEcCtD
Ceftazidime—Abdominal pain—Losartan—type 2 diabetes mellitus	9.49e-05	0.000421	CcSEcCtD
Ceftazidime—SLC22A5—SLC-mediated transmembrane transport—G6PC—type 2 diabetes mellitus	9.49e-05	0.0103	CbGpPWpGaD
Ceftazidime—Vomiting—Valsartan—type 2 diabetes mellitus	9.44e-05	0.000419	CcSEcCtD
Ceftazidime—Hypersensitivity—Irbesartan—type 2 diabetes mellitus	9.4e-05	0.000417	CcSEcCtD
Ceftazidime—Rash—Valsartan—type 2 diabetes mellitus	9.36e-05	0.000415	CcSEcCtD
Ceftazidime—Dermatitis—Valsartan—type 2 diabetes mellitus	9.35e-05	0.000415	CcSEcCtD
Ceftazidime—Vomiting—Orlistat—type 2 diabetes mellitus	9.33e-05	0.000414	CcSEcCtD
Ceftazidime—Headache—Valsartan—type 2 diabetes mellitus	9.3e-05	0.000413	CcSEcCtD
Ceftazidime—Diarrhoea—Metformin—type 2 diabetes mellitus	9.25e-05	0.00041	CcSEcCtD
Ceftazidime—Rash—Orlistat—type 2 diabetes mellitus	9.25e-05	0.00041	CcSEcCtD
Ceftazidime—Paraesthesia—Ramipril—type 2 diabetes mellitus	9.24e-05	0.00041	CcSEcCtD
Ceftazidime—Dermatitis—Orlistat—type 2 diabetes mellitus	9.24e-05	0.00041	CcSEcCtD
Ceftazidime—Headache—Orlistat—type 2 diabetes mellitus	9.19e-05	0.000408	CcSEcCtD
Ceftazidime—Pruritus—Irbesartan—type 2 diabetes mellitus	9.03e-05	0.0004	CcSEcCtD
Ceftazidime—Dizziness—Metformin—type 2 diabetes mellitus	8.94e-05	0.000397	CcSEcCtD
Ceftazidime—Gastrointestinal disorder—Ramipril—type 2 diabetes mellitus	8.89e-05	0.000394	CcSEcCtD
Ceftazidime—Hypersensitivity—Losartan—type 2 diabetes mellitus	8.85e-05	0.000392	CcSEcCtD
Ceftazidime—Nausea—Valsartan—type 2 diabetes mellitus	8.82e-05	0.000391	CcSEcCtD
Ceftazidime—Diarrhoea—Irbesartan—type 2 diabetes mellitus	8.73e-05	0.000387	CcSEcCtD
Ceftazidime—Nausea—Orlistat—type 2 diabetes mellitus	8.71e-05	0.000386	CcSEcCtD
Ceftazidime—Vomiting—Metformin—type 2 diabetes mellitus	8.6e-05	0.000381	CcSEcCtD
Ceftazidime—Rash—Metformin—type 2 diabetes mellitus	8.52e-05	0.000378	CcSEcCtD
Ceftazidime—Dermatitis—Metformin—type 2 diabetes mellitus	8.52e-05	0.000378	CcSEcCtD
Ceftazidime—Pruritus—Losartan—type 2 diabetes mellitus	8.49e-05	0.000377	CcSEcCtD
Ceftazidime—SLC15A2—SLC-mediated transmembrane transport—SLC30A8—type 2 diabetes mellitus	8.47e-05	0.00922	CbGpPWpGaD
Ceftazidime—Headache—Metformin—type 2 diabetes mellitus	8.47e-05	0.000376	CcSEcCtD
Ceftazidime—SLC22A6—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—SLC2A2—type 2 diabetes mellitus	8.45e-05	0.0092	CbGpPWpGaD
Ceftazidime—Dizziness—Irbesartan—type 2 diabetes mellitus	8.44e-05	0.000374	CcSEcCtD
Ceftazidime—Gastrointestinal pain—Ramipril—type 2 diabetes mellitus	8.42e-05	0.000373	CcSEcCtD
Ceftazidime—SLC22A5—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—SLC2A4—type 2 diabetes mellitus	8.31e-05	0.00905	CbGpPWpGaD
Ceftazidime—Diarrhoea—Losartan—type 2 diabetes mellitus	8.22e-05	0.000364	CcSEcCtD
Ceftazidime—SLC15A2—Transmembrane transport of small molecules—SLC26A9—type 2 diabetes mellitus	8.2e-05	0.00892	CbGpPWpGaD
Ceftazidime—Urticaria—Ramipril—type 2 diabetes mellitus	8.18e-05	0.000363	CcSEcCtD
Ceftazidime—SLC15A2—SLC-mediated transmembrane transport—SLC5A2—type 2 diabetes mellitus	8.16e-05	0.00888	CbGpPWpGaD
Ceftazidime—Abdominal pain—Ramipril—type 2 diabetes mellitus	8.14e-05	0.000361	CcSEcCtD
Ceftazidime—Body temperature increased—Ramipril—type 2 diabetes mellitus	8.14e-05	0.000361	CcSEcCtD
Ceftazidime—Vomiting—Irbesartan—type 2 diabetes mellitus	8.11e-05	0.00036	CcSEcCtD
Ceftazidime—Rash—Irbesartan—type 2 diabetes mellitus	8.04e-05	0.000357	CcSEcCtD
Ceftazidime—Dermatitis—Irbesartan—type 2 diabetes mellitus	8.04e-05	0.000356	CcSEcCtD
Ceftazidime—Nausea—Metformin—type 2 diabetes mellitus	8.03e-05	0.000356	CcSEcCtD
Ceftazidime—Headache—Irbesartan—type 2 diabetes mellitus	7.99e-05	0.000355	CcSEcCtD
Ceftazidime—Dizziness—Losartan—type 2 diabetes mellitus	7.94e-05	0.000352	CcSEcCtD
Ceftazidime—SLC15A1—SLC-mediated transmembrane transport—SLC30A8—type 2 diabetes mellitus	7.86e-05	0.00856	CbGpPWpGaD
Ceftazidime—SLC22A5—SLC-mediated transmembrane transport—SLC30A8—type 2 diabetes mellitus	7.73e-05	0.00842	CbGpPWpGaD
Ceftazidime—Vomiting—Losartan—type 2 diabetes mellitus	7.63e-05	0.000339	CcSEcCtD
Ceftazidime—SLC15A1—Transmembrane transport of small molecules—SLC26A9—type 2 diabetes mellitus	7.61e-05	0.00828	CbGpPWpGaD
Ceftazidime—Hypersensitivity—Ramipril—type 2 diabetes mellitus	7.59e-05	0.000336	CcSEcCtD
Ceftazidime—Nausea—Irbesartan—type 2 diabetes mellitus	7.58e-05	0.000336	CcSEcCtD
Ceftazidime—Rash—Losartan—type 2 diabetes mellitus	7.57e-05	0.000336	CcSEcCtD
Ceftazidime—SLC15A1—SLC-mediated transmembrane transport—SLC5A2—type 2 diabetes mellitus	7.57e-05	0.00824	CbGpPWpGaD
Ceftazidime—Dermatitis—Losartan—type 2 diabetes mellitus	7.56e-05	0.000335	CcSEcCtD
Ceftazidime—Headache—Losartan—type 2 diabetes mellitus	7.52e-05	0.000334	CcSEcCtD
Ceftazidime—SLC22A5—Transmembrane transport of small molecules—SLC26A9—type 2 diabetes mellitus	7.48e-05	0.00814	CbGpPWpGaD
Ceftazidime—SLC22A5—SLC-mediated transmembrane transport—SLC5A2—type 2 diabetes mellitus	7.44e-05	0.0081	CbGpPWpGaD
Ceftazidime—SLC22A6—SLC-mediated transmembrane transport—SLC5A4—type 2 diabetes mellitus	7.41e-05	0.00807	CbGpPWpGaD
Ceftazidime—Pruritus—Ramipril—type 2 diabetes mellitus	7.28e-05	0.000323	CcSEcCtD
Ceftazidime—SLC22A6—SLC-mediated transmembrane transport—G6PC—type 2 diabetes mellitus	7.16e-05	0.0078	CbGpPWpGaD
Ceftazidime—Nausea—Losartan—type 2 diabetes mellitus	7.13e-05	0.000316	CcSEcCtD
Ceftazidime—Diarrhoea—Ramipril—type 2 diabetes mellitus	7.04e-05	0.000312	CcSEcCtD
Ceftazidime—SLC15A2—SLC-mediated transmembrane transport—HK1—type 2 diabetes mellitus	6.94e-05	0.00755	CbGpPWpGaD
Ceftazidime—Dizziness—Ramipril—type 2 diabetes mellitus	6.81e-05	0.000302	CcSEcCtD
Ceftazidime—SLC15A2—SLC-mediated transmembrane transport—GCKR—type 2 diabetes mellitus	6.7e-05	0.00729	CbGpPWpGaD
Ceftazidime—Vomiting—Ramipril—type 2 diabetes mellitus	6.55e-05	0.00029	CcSEcCtD
Ceftazidime—Rash—Ramipril—type 2 diabetes mellitus	6.49e-05	0.000288	CcSEcCtD
Ceftazidime—Dermatitis—Ramipril—type 2 diabetes mellitus	6.49e-05	0.000288	CcSEcCtD
Ceftazidime—Headache—Ramipril—type 2 diabetes mellitus	6.45e-05	0.000286	CcSEcCtD
Ceftazidime—SLC15A1—SLC-mediated transmembrane transport—HK1—type 2 diabetes mellitus	6.44e-05	0.00701	CbGpPWpGaD
Ceftazidime—SLC22A5—SLC-mediated transmembrane transport—HK1—type 2 diabetes mellitus	6.33e-05	0.00689	CbGpPWpGaD
Ceftazidime—SLC22A6—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—SLC2A4—type 2 diabetes mellitus	6.27e-05	0.00683	CbGpPWpGaD
Ceftazidime—SLC15A1—SLC-mediated transmembrane transport—GCKR—type 2 diabetes mellitus	6.22e-05	0.00677	CbGpPWpGaD
Ceftazidime—Nausea—Ramipril—type 2 diabetes mellitus	6.12e-05	0.000271	CcSEcCtD
Ceftazidime—SLC22A5—SLC-mediated transmembrane transport—GCKR—type 2 diabetes mellitus	6.11e-05	0.00666	CbGpPWpGaD
Ceftazidime—SLC22A6—SLC-mediated transmembrane transport—SLC30A8—type 2 diabetes mellitus	5.84e-05	0.00635	CbGpPWpGaD
Ceftazidime—SLC22A6—Transmembrane transport of small molecules—SLC26A9—type 2 diabetes mellitus	5.65e-05	0.00615	CbGpPWpGaD
Ceftazidime—SLC22A6—SLC-mediated transmembrane transport—SLC5A2—type 2 diabetes mellitus	5.62e-05	0.00612	CbGpPWpGaD
Ceftazidime—SLC15A2—SLC-mediated transmembrane transport—SLC2A2—type 2 diabetes mellitus	5.57e-05	0.00607	CbGpPWpGaD
Ceftazidime—SLC15A2—Transmembrane transport of small molecules—SLC5A4—type 2 diabetes mellitus	5.47e-05	0.00595	CbGpPWpGaD
Ceftazidime—SLC15A2—SLC-mediated transmembrane transport—GCK—type 2 diabetes mellitus	5.32e-05	0.00579	CbGpPWpGaD
Ceftazidime—SLC15A2—Transmembrane transport of small molecules—G6PC—type 2 diabetes mellitus	5.28e-05	0.00575	CbGpPWpGaD
Ceftazidime—SLC15A2—Transmembrane transport of small molecules—TRPC1—type 2 diabetes mellitus	5.28e-05	0.00575	CbGpPWpGaD
Ceftazidime—SLC15A2—SLC-mediated transmembrane transport—SLC9A1—type 2 diabetes mellitus	5.19e-05	0.00565	CbGpPWpGaD
Ceftazidime—SLC15A1—SLC-mediated transmembrane transport—SLC2A2—type 2 diabetes mellitus	5.17e-05	0.00563	CbGpPWpGaD
Ceftazidime—SLC22A5—SLC-mediated transmembrane transport—SLC2A2—type 2 diabetes mellitus	5.09e-05	0.00554	CbGpPWpGaD
Ceftazidime—SLC15A1—Transmembrane transport of small molecules—SLC5A4—type 2 diabetes mellitus	5.08e-05	0.00553	CbGpPWpGaD
Ceftazidime—SLC22A5—Transmembrane transport of small molecules—SLC5A4—type 2 diabetes mellitus	4.99e-05	0.00543	CbGpPWpGaD
Ceftazidime—SLC15A1—SLC-mediated transmembrane transport—GCK—type 2 diabetes mellitus	4.94e-05	0.00538	CbGpPWpGaD
Ceftazidime—SLC15A1—Transmembrane transport of small molecules—G6PC—type 2 diabetes mellitus	4.9e-05	0.00534	CbGpPWpGaD
Ceftazidime—SLC15A1—Transmembrane transport of small molecules—TRPC1—type 2 diabetes mellitus	4.9e-05	0.00534	CbGpPWpGaD
Ceftazidime—SLC22A5—SLC-mediated transmembrane transport—GCK—type 2 diabetes mellitus	4.86e-05	0.00529	CbGpPWpGaD
Ceftazidime—SLC15A2—Transmembrane transport of small molecules—PLN—type 2 diabetes mellitus	4.83e-05	0.00526	CbGpPWpGaD
Ceftazidime—SLC22A5—Transmembrane transport of small molecules—G6PC—type 2 diabetes mellitus	4.82e-05	0.00525	CbGpPWpGaD
Ceftazidime—SLC22A5—Transmembrane transport of small molecules—TRPC1—type 2 diabetes mellitus	4.82e-05	0.00525	CbGpPWpGaD
Ceftazidime—SLC15A1—SLC-mediated transmembrane transport—SLC9A1—type 2 diabetes mellitus	4.82e-05	0.00525	CbGpPWpGaD
Ceftazidime—SLC22A6—SLC-mediated transmembrane transport—HK1—type 2 diabetes mellitus	4.78e-05	0.0052	CbGpPWpGaD
Ceftazidime—SLC22A5—SLC-mediated transmembrane transport—SLC9A1—type 2 diabetes mellitus	4.74e-05	0.00516	CbGpPWpGaD
Ceftazidime—SLC22A6—SLC-mediated transmembrane transport—GCKR—type 2 diabetes mellitus	4.61e-05	0.00502	CbGpPWpGaD
Ceftazidime—SLC15A1—Transmembrane transport of small molecules—PLN—type 2 diabetes mellitus	4.48e-05	0.00488	CbGpPWpGaD
Ceftazidime—SLC22A5—Transmembrane transport of small molecules—PLN—type 2 diabetes mellitus	4.41e-05	0.0048	CbGpPWpGaD
Ceftazidime—SLC15A2—SLC-mediated transmembrane transport—SLC2A1—type 2 diabetes mellitus	4.32e-05	0.0047	CbGpPWpGaD
Ceftazidime—SLC15A2—Transmembrane transport of small molecules—ABCC8—type 2 diabetes mellitus	4.31e-05	0.00469	CbGpPWpGaD
Ceftazidime—SLC15A2—Transmembrane transport of small molecules—SLC30A8—type 2 diabetes mellitus	4.31e-05	0.00469	CbGpPWpGaD
Ceftazidime—SLC15A2—Transmembrane transport of small molecules—SLC5A2—type 2 diabetes mellitus	4.14e-05	0.00451	CbGpPWpGaD
Ceftazidime—SLC15A2—Transmembrane transport of small molecules—COX2—type 2 diabetes mellitus	4.14e-05	0.00451	CbGpPWpGaD
Ceftazidime—SLC15A2—SLC-mediated transmembrane transport—SLC2A4—type 2 diabetes mellitus	4.14e-05	0.0045	CbGpPWpGaD
Ceftazidime—SLC15A2—Transmembrane transport of small molecules—NCOA6—type 2 diabetes mellitus	4.07e-05	0.00443	CbGpPWpGaD
Ceftazidime—SLC15A1—SLC-mediated transmembrane transport—SLC2A1—type 2 diabetes mellitus	4.01e-05	0.00436	CbGpPWpGaD
Ceftazidime—SLC15A1—Transmembrane transport of small molecules—SLC30A8—type 2 diabetes mellitus	4e-05	0.00435	CbGpPWpGaD
Ceftazidime—SLC15A1—Transmembrane transport of small molecules—ABCC8—type 2 diabetes mellitus	4e-05	0.00435	CbGpPWpGaD
Ceftazidime—SLC22A5—SLC-mediated transmembrane transport—SLC2A1—type 2 diabetes mellitus	3.94e-05	0.00429	CbGpPWpGaD
Ceftazidime—SLC22A5—Transmembrane transport of small molecules—ABCC8—type 2 diabetes mellitus	3.93e-05	0.00428	CbGpPWpGaD
Ceftazidime—SLC22A5—Transmembrane transport of small molecules—SLC30A8—type 2 diabetes mellitus	3.93e-05	0.00428	CbGpPWpGaD
Ceftazidime—SLC15A1—Transmembrane transport of small molecules—COX2—type 2 diabetes mellitus	3.85e-05	0.00419	CbGpPWpGaD
Ceftazidime—SLC15A1—Transmembrane transport of small molecules—SLC5A2—type 2 diabetes mellitus	3.85e-05	0.00419	CbGpPWpGaD
Ceftazidime—SLC15A1—SLC-mediated transmembrane transport—SLC2A4—type 2 diabetes mellitus	3.84e-05	0.00418	CbGpPWpGaD
Ceftazidime—SLC22A6—SLC-mediated transmembrane transport—SLC2A2—type 2 diabetes mellitus	3.84e-05	0.00418	CbGpPWpGaD
Ceftazidime—SLC22A5—Transmembrane transport of small molecules—COX2—type 2 diabetes mellitus	3.78e-05	0.00412	CbGpPWpGaD
Ceftazidime—SLC22A5—Transmembrane transport of small molecules—SLC5A2—type 2 diabetes mellitus	3.78e-05	0.00412	CbGpPWpGaD
Ceftazidime—SLC15A1—Transmembrane transport of small molecules—NCOA6—type 2 diabetes mellitus	3.78e-05	0.00411	CbGpPWpGaD
Ceftazidime—SLC22A5—SLC-mediated transmembrane transport—SLC2A4—type 2 diabetes mellitus	3.78e-05	0.00411	CbGpPWpGaD
Ceftazidime—SLC22A6—Transmembrane transport of small molecules—SLC5A4—type 2 diabetes mellitus	3.77e-05	0.0041	CbGpPWpGaD
Ceftazidime—SLC15A2—Transmembrane transport of small molecules—ATP2A3—type 2 diabetes mellitus	3.76e-05	0.0041	CbGpPWpGaD
Ceftazidime—SLC22A5—Transmembrane transport of small molecules—NCOA6—type 2 diabetes mellitus	3.72e-05	0.00405	CbGpPWpGaD
Ceftazidime—SLC22A6—SLC-mediated transmembrane transport—GCK—type 2 diabetes mellitus	3.67e-05	0.00399	CbGpPWpGaD
Ceftazidime—SLC22A6—Transmembrane transport of small molecules—G6PC—type 2 diabetes mellitus	3.64e-05	0.00396	CbGpPWpGaD
Ceftazidime—SLC22A6—Transmembrane transport of small molecules—TRPC1—type 2 diabetes mellitus	3.64e-05	0.00396	CbGpPWpGaD
Ceftazidime—SLC22A6—SLC-mediated transmembrane transport—SLC9A1—type 2 diabetes mellitus	3.58e-05	0.0039	CbGpPWpGaD
Ceftazidime—SLC15A2—Transmembrane transport of small molecules—HK1—type 2 diabetes mellitus	3.52e-05	0.00384	CbGpPWpGaD
Ceftazidime—SLC15A2—SLC-mediated transmembrane transport—AVP—type 2 diabetes mellitus	3.52e-05	0.00383	CbGpPWpGaD
Ceftazidime—SLC15A1—Transmembrane transport of small molecules—ATP2A3—type 2 diabetes mellitus	3.49e-05	0.0038	CbGpPWpGaD
Ceftazidime—SLC22A5—Transmembrane transport of small molecules—ATP2A3—type 2 diabetes mellitus	3.44e-05	0.00374	CbGpPWpGaD
Ceftazidime—SLC15A2—Transmembrane transport of small molecules—GCKR—type 2 diabetes mellitus	3.4e-05	0.00371	CbGpPWpGaD
Ceftazidime—SLC22A6—Transmembrane transport of small molecules—PLN—type 2 diabetes mellitus	3.33e-05	0.00362	CbGpPWpGaD
Ceftazidime—SLC15A1—Transmembrane transport of small molecules—HK1—type 2 diabetes mellitus	3.27e-05	0.00356	CbGpPWpGaD
Ceftazidime—SLC15A1—SLC-mediated transmembrane transport—AVP—type 2 diabetes mellitus	3.27e-05	0.00355	CbGpPWpGaD
Ceftazidime—SLC15A2—Transmembrane transport of small molecules—ABCC2—type 2 diabetes mellitus	3.26e-05	0.00355	CbGpPWpGaD
Ceftazidime—SLC22A5—Transmembrane transport of small molecules—HK1—type 2 diabetes mellitus	3.22e-05	0.0035	CbGpPWpGaD
Ceftazidime—SLC22A5—SLC-mediated transmembrane transport—AVP—type 2 diabetes mellitus	3.21e-05	0.0035	CbGpPWpGaD
Ceftazidime—SLC15A1—Transmembrane transport of small molecules—GCKR—type 2 diabetes mellitus	3.16e-05	0.00344	CbGpPWpGaD
Ceftazidime—SLC22A5—Transmembrane transport of small molecules—GCKR—type 2 diabetes mellitus	3.11e-05	0.00338	CbGpPWpGaD
Ceftazidime—SLC15A1—Transmembrane transport of small molecules—ABCC2—type 2 diabetes mellitus	3.03e-05	0.0033	CbGpPWpGaD
Ceftazidime—SLC22A5—Transmembrane transport of small molecules—ABCC2—type 2 diabetes mellitus	2.98e-05	0.00324	CbGpPWpGaD
Ceftazidime—SLC22A6—SLC-mediated transmembrane transport—SLC2A1—type 2 diabetes mellitus	2.97e-05	0.00324	CbGpPWpGaD
Ceftazidime—SLC22A6—Transmembrane transport of small molecules—SLC30A8—type 2 diabetes mellitus	2.97e-05	0.00323	CbGpPWpGaD
Ceftazidime—SLC22A6—Transmembrane transport of small molecules—ABCC8—type 2 diabetes mellitus	2.97e-05	0.00323	CbGpPWpGaD
Ceftazidime—SLC22A6—Transmembrane transport of small molecules—SLC5A2—type 2 diabetes mellitus	2.86e-05	0.00311	CbGpPWpGaD
Ceftazidime—SLC22A6—Transmembrane transport of small molecules—COX2—type 2 diabetes mellitus	2.86e-05	0.00311	CbGpPWpGaD
Ceftazidime—SLC22A6—SLC-mediated transmembrane transport—SLC2A4—type 2 diabetes mellitus	2.85e-05	0.0031	CbGpPWpGaD
Ceftazidime—SLC15A2—Transmembrane transport of small molecules—SLC2A2—type 2 diabetes mellitus	2.83e-05	0.00308	CbGpPWpGaD
Ceftazidime—SLC22A6—Transmembrane transport of small molecules—NCOA6—type 2 diabetes mellitus	2.81e-05	0.00305	CbGpPWpGaD
Ceftazidime—SLC15A2—Transmembrane transport of small molecules—ATP2A2—type 2 diabetes mellitus	2.7e-05	0.00294	CbGpPWpGaD
Ceftazidime—SLC15A2—Transmembrane transport of small molecules—GCK—type 2 diabetes mellitus	2.7e-05	0.00294	CbGpPWpGaD
Ceftazidime—SLC15A2—Transmembrane transport of small molecules—SLC9A1—type 2 diabetes mellitus	2.64e-05	0.00287	CbGpPWpGaD
Ceftazidime—SLC15A1—Transmembrane transport of small molecules—SLC2A2—type 2 diabetes mellitus	2.63e-05	0.00286	CbGpPWpGaD
Ceftazidime—SLC15A2—Transmembrane transport of small molecules—TRPC6—type 2 diabetes mellitus	2.62e-05	0.00286	CbGpPWpGaD
Ceftazidime—SLC15A2—Transmembrane transport of small molecules—CETP—type 2 diabetes mellitus	2.61e-05	0.00284	CbGpPWpGaD
Ceftazidime—SLC22A6—Transmembrane transport of small molecules—ATP2A3—type 2 diabetes mellitus	2.59e-05	0.00282	CbGpPWpGaD
Ceftazidime—SLC22A5—Transmembrane transport of small molecules—SLC2A2—type 2 diabetes mellitus	2.59e-05	0.00281	CbGpPWpGaD
Ceftazidime—SLC15A1—Transmembrane transport of small molecules—GCK—type 2 diabetes mellitus	2.51e-05	0.00273	CbGpPWpGaD
Ceftazidime—SLC15A1—Transmembrane transport of small molecules—ATP2A2—type 2 diabetes mellitus	2.51e-05	0.00273	CbGpPWpGaD
Ceftazidime—SLC22A5—Transmembrane transport of small molecules—ATP2A2—type 2 diabetes mellitus	2.47e-05	0.00269	CbGpPWpGaD
Ceftazidime—SLC22A5—Transmembrane transport of small molecules—GCK—type 2 diabetes mellitus	2.47e-05	0.00269	CbGpPWpGaD
Ceftazidime—SLC15A1—Transmembrane transport of small molecules—SLC9A1—type 2 diabetes mellitus	2.45e-05	0.00267	CbGpPWpGaD
Ceftazidime—SLC15A1—Transmembrane transport of small molecules—TRPC6—type 2 diabetes mellitus	2.44e-05	0.00265	CbGpPWpGaD
Ceftazidime—SLC22A6—Transmembrane transport of small molecules—HK1—type 2 diabetes mellitus	2.43e-05	0.00264	CbGpPWpGaD
Ceftazidime—SLC22A6—SLC-mediated transmembrane transport—AVP—type 2 diabetes mellitus	2.42e-05	0.00264	CbGpPWpGaD
Ceftazidime—SLC15A1—Transmembrane transport of small molecules—CETP—type 2 diabetes mellitus	2.42e-05	0.00264	CbGpPWpGaD
Ceftazidime—SLC22A5—Transmembrane transport of small molecules—SLC9A1—type 2 diabetes mellitus	2.41e-05	0.00262	CbGpPWpGaD
Ceftazidime—SLC22A5—Transmembrane transport of small molecules—TRPC6—type 2 diabetes mellitus	2.39e-05	0.00261	CbGpPWpGaD
Ceftazidime—SLC22A5—Transmembrane transport of small molecules—CETP—type 2 diabetes mellitus	2.38e-05	0.00259	CbGpPWpGaD
Ceftazidime—SLC22A6—Transmembrane transport of small molecules—GCKR—type 2 diabetes mellitus	2.34e-05	0.00255	CbGpPWpGaD
Ceftazidime—SLC15A2—Transmembrane transport of small molecules—PLAT—type 2 diabetes mellitus	2.3e-05	0.0025	CbGpPWpGaD
Ceftazidime—SLC22A6—Transmembrane transport of small molecules—ABCC2—type 2 diabetes mellitus	2.25e-05	0.00245	CbGpPWpGaD
Ceftazidime—SLC15A2—Transmembrane transport of small molecules—SLC2A1—type 2 diabetes mellitus	2.19e-05	0.00239	CbGpPWpGaD
Ceftazidime—SLC15A1—Transmembrane transport of small molecules—PLAT—type 2 diabetes mellitus	2.13e-05	0.00232	CbGpPWpGaD
Ceftazidime—SLC15A2—SLC-mediated transmembrane transport—ALB—type 2 diabetes mellitus	2.13e-05	0.00232	CbGpPWpGaD
Ceftazidime—SLC15A2—Transmembrane transport of small molecules—SLC2A4—type 2 diabetes mellitus	2.1e-05	0.00229	CbGpPWpGaD
Ceftazidime—SLC22A5—Transmembrane transport of small molecules—PLAT—type 2 diabetes mellitus	2.1e-05	0.00228	CbGpPWpGaD
Ceftazidime—SLC15A1—Transmembrane transport of small molecules—SLC2A1—type 2 diabetes mellitus	2.04e-05	0.00222	CbGpPWpGaD
Ceftazidime—SLC22A5—Transmembrane transport of small molecules—SLC2A1—type 2 diabetes mellitus	2e-05	0.00218	CbGpPWpGaD
Ceftazidime—SLC15A1—SLC-mediated transmembrane transport—ALB—type 2 diabetes mellitus	1.98e-05	0.00215	CbGpPWpGaD
Ceftazidime—SLC15A1—Transmembrane transport of small molecules—SLC2A4—type 2 diabetes mellitus	1.95e-05	0.00212	CbGpPWpGaD
Ceftazidime—SLC22A6—Transmembrane transport of small molecules—SLC2A2—type 2 diabetes mellitus	1.95e-05	0.00212	CbGpPWpGaD
Ceftazidime—SLC22A5—SLC-mediated transmembrane transport—ALB—type 2 diabetes mellitus	1.95e-05	0.00212	CbGpPWpGaD
Ceftazidime—SLC22A5—Transmembrane transport of small molecules—SLC2A4—type 2 diabetes mellitus	1.92e-05	0.00209	CbGpPWpGaD
Ceftazidime—SLC22A6—Transmembrane transport of small molecules—ATP2A2—type 2 diabetes mellitus	1.86e-05	0.00203	CbGpPWpGaD
Ceftazidime—SLC22A6—Transmembrane transport of small molecules—GCK—type 2 diabetes mellitus	1.86e-05	0.00203	CbGpPWpGaD
Ceftazidime—SLC22A6—Transmembrane transport of small molecules—SLC9A1—type 2 diabetes mellitus	1.82e-05	0.00198	CbGpPWpGaD
Ceftazidime—SLC15A2—Transmembrane transport of small molecules—GNB3—type 2 diabetes mellitus	1.81e-05	0.00197	CbGpPWpGaD
Ceftazidime—SLC22A6—Transmembrane transport of small molecules—TRPC6—type 2 diabetes mellitus	1.81e-05	0.00197	CbGpPWpGaD
Ceftazidime—SLC15A2—Transmembrane transport of small molecules—HMOX1—type 2 diabetes mellitus	1.8e-05	0.00196	CbGpPWpGaD
Ceftazidime—SLC22A6—Transmembrane transport of small molecules—CETP—type 2 diabetes mellitus	1.8e-05	0.00196	CbGpPWpGaD
Ceftazidime—SLC15A2—Transmembrane transport of small molecules—AVP—type 2 diabetes mellitus	1.79e-05	0.00195	CbGpPWpGaD
Ceftazidime—SLC15A2—Transmembrane transport of small molecules—APOB—type 2 diabetes mellitus	1.73e-05	0.00188	CbGpPWpGaD
Ceftazidime—SLC15A1—Transmembrane transport of small molecules—GNB3—type 2 diabetes mellitus	1.68e-05	0.00183	CbGpPWpGaD
Ceftazidime—SLC15A1—Transmembrane transport of small molecules—HMOX1—type 2 diabetes mellitus	1.67e-05	0.00182	CbGpPWpGaD
Ceftazidime—SLC15A1—Transmembrane transport of small molecules—AVP—type 2 diabetes mellitus	1.66e-05	0.00181	CbGpPWpGaD
Ceftazidime—SLC22A5—Transmembrane transport of small molecules—GNB3—type 2 diabetes mellitus	1.65e-05	0.0018	CbGpPWpGaD
Ceftazidime—SLC22A5—Transmembrane transport of small molecules—HMOX1—type 2 diabetes mellitus	1.65e-05	0.00179	CbGpPWpGaD
Ceftazidime—SLC22A5—Transmembrane transport of small molecules—AVP—type 2 diabetes mellitus	1.63e-05	0.00178	CbGpPWpGaD
Ceftazidime—SLC15A2—Transmembrane transport of small molecules—ADCY5—type 2 diabetes mellitus	1.62e-05	0.00176	CbGpPWpGaD
Ceftazidime—SLC15A1—Transmembrane transport of small molecules—APOB—type 2 diabetes mellitus	1.6e-05	0.00175	CbGpPWpGaD
Ceftazidime—SLC22A6—Transmembrane transport of small molecules—PLAT—type 2 diabetes mellitus	1.58e-05	0.00172	CbGpPWpGaD
Ceftazidime—SLC22A5—Transmembrane transport of small molecules—APOB—type 2 diabetes mellitus	1.58e-05	0.00172	CbGpPWpGaD
Ceftazidime—SLC22A6—Transmembrane transport of small molecules—SLC2A1—type 2 diabetes mellitus	1.51e-05	0.00164	CbGpPWpGaD
Ceftazidime—SLC15A1—Transmembrane transport of small molecules—ADCY5—type 2 diabetes mellitus	1.5e-05	0.00163	CbGpPWpGaD
Ceftazidime—SLC22A5—Transmembrane transport of small molecules—ADCY5—type 2 diabetes mellitus	1.47e-05	0.00161	CbGpPWpGaD
Ceftazidime—SLC22A6—SLC-mediated transmembrane transport—ALB—type 2 diabetes mellitus	1.47e-05	0.0016	CbGpPWpGaD
Ceftazidime—SLC15A2—Transmembrane transport of small molecules—PPARA—type 2 diabetes mellitus	1.46e-05	0.00159	CbGpPWpGaD
Ceftazidime—SLC22A6—Transmembrane transport of small molecules—SLC2A4—type 2 diabetes mellitus	1.45e-05	0.00158	CbGpPWpGaD
Ceftazidime—SLC15A2—Transmembrane transport of small molecules—APOA1—type 2 diabetes mellitus	1.37e-05	0.00149	CbGpPWpGaD
Ceftazidime—SLC15A1—Transmembrane transport of small molecules—PPARA—type 2 diabetes mellitus	1.35e-05	0.00147	CbGpPWpGaD
Ceftazidime—SLC22A5—Transmembrane transport of small molecules—PPARA—type 2 diabetes mellitus	1.33e-05	0.00145	CbGpPWpGaD
Ceftazidime—SLC15A1—Transmembrane transport of small molecules—APOA1—type 2 diabetes mellitus	1.27e-05	0.00138	CbGpPWpGaD
Ceftazidime—SLC22A6—Transmembrane transport of small molecules—GNB3—type 2 diabetes mellitus	1.25e-05	0.00136	CbGpPWpGaD
Ceftazidime—SLC22A5—Transmembrane transport of small molecules—APOA1—type 2 diabetes mellitus	1.25e-05	0.00136	CbGpPWpGaD
Ceftazidime—SLC22A6—Transmembrane transport of small molecules—HMOX1—type 2 diabetes mellitus	1.24e-05	0.00135	CbGpPWpGaD
Ceftazidime—SLC22A6—Transmembrane transport of small molecules—AVP—type 2 diabetes mellitus	1.23e-05	0.00134	CbGpPWpGaD
Ceftazidime—SLC22A6—Transmembrane transport of small molecules—APOB—type 2 diabetes mellitus	1.19e-05	0.0013	CbGpPWpGaD
Ceftazidime—SLC22A6—Transmembrane transport of small molecules—ADCY5—type 2 diabetes mellitus	1.11e-05	0.00121	CbGpPWpGaD
Ceftazidime—SLC15A2—Transmembrane transport of small molecules—ALB—type 2 diabetes mellitus	1.08e-05	0.00118	CbGpPWpGaD
Ceftazidime—SLC15A1—Transmembrane transport of small molecules—ALB—type 2 diabetes mellitus	1.01e-05	0.00109	CbGpPWpGaD
Ceftazidime—SLC22A6—Transmembrane transport of small molecules—PPARA—type 2 diabetes mellitus	1e-05	0.00109	CbGpPWpGaD
Ceftazidime—SLC22A5—Transmembrane transport of small molecules—ALB—type 2 diabetes mellitus	9.89e-06	0.00108	CbGpPWpGaD
Ceftazidime—SLC22A6—Transmembrane transport of small molecules—APOA1—type 2 diabetes mellitus	9.42e-06	0.00103	CbGpPWpGaD
Ceftazidime—SLC22A6—Transmembrane transport of small molecules—ALB—type 2 diabetes mellitus	7.46e-06	0.000812	CbGpPWpGaD
